From: Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
Variable (n = 1071) | Unadjusted prevalence ratio (95% CI) | P-value | Adjusted prevalence ratio**‡ (95% CI) | P-value*** |
---|---|---|---|---|
Hospitalization (ref = not hospitalized) | 3.1 (2.1–4.4) |  < 0.001 | 2.8 (1.8–4.5) |  < 0.001 |
Treatment delay (ref =  < 4 weeks) | 1.6 (1.2–1.9) |  < 0.001 | 1.5 (1.3–1.7) |  < 0.001 |
Type of facility offering treatment (ref = private) | 0.8 (0.6–0.9) | 0.032 | 0.8 (0.6–0.9) | 0.021 |
BMI | 0.98 (0.97–0.99) |  < 0.001 | 0.97 (0.96–0.98) |  < 0.001 |
Pre-TB HH exp_quintiles (ref = Quintile 5) |  |  |  |  |
Poorest Q1 | 6.3 (3.9–10.3) |  < 0.001 | 6.2 (4.0–9.7) |  < 0.001 |
Q2 | 3.40 (2.1–5.6) |  < 0.001 | 3.4 (2.1–5.3) |  < 0.001 |
Q3 | 2.5 (1.4– 4.2) | 0.002 | 2.4 (1.5–3.9) |  < 0.001 |
Q4 | 1.7 (0.9–3.2) | 0.111 | 1.6 (0.9–3.0) | 0.110 |
TB type (ref = EPTB†) | 0.8 (0.6–1.0) | 0.050 |  |  |
X-ray test (ref = no X-Ray) | 1.3 (1.1–1.56) | 0.018 | 1.1 (0.9–1.4) | 0.147 |
Constant |  |  | 0.19 |  < 0.001 |